Cooperatieve AESCAP Venture I U.A. 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-26 4:31 pm Unchanged |
2021-05-12 | 13D | F-star Therapeutics, Inc. FSTX |
Cooperatieve AESCAP Venture I U.A. | 615,643 3.100% |
0 (Unchanged) |
Filing |
| 2020-12-03 5:08 pm Purchase |
2020-11-20 | 13D | F-star Therapeutics, Inc. FSTX |
Cooperatieve AESCAP Venture I U.A. | 615,643 6.800% |
615,643 (New Position) |
Filing |